SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Jun-24 7:24 PM View: | Neurobo Pharmaceuticals, Inc. (NRBO) | 07-Jun-24 | Grant | 5,051 | -- | -- | 126% 4.02K to 9.07K | |
04-Dec-23 5:12 PM View: | Neurobo Pharmaceuticals, Inc. (NRBO) | 01-Dec-23 | Grant | 32,157 | -- | -- | 100% 0 to 32.16K | |
17-Aug-22 6:31 AM View: | Endo International plc (ENDP) | 15-Jul-22 | Disposition | 280,373 | -- | -- | (100%) 280.37K to 0 | |
10-Jun-22 4:45 PM View: | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 48% 1.4K to 2.07K | |
10-Jun-21 7:08 PM View: | Agile Therapeutics, Inc. (AGRX) | 08-Jun-21 | Grant | 24,510 | -- | -- | 78% 31.34K to 55.85K | |
11-Jun-20 5:22 PM View: | Agile Therapeutics, Inc. (AGRX) | 09-Jun-20 | Grant | 13,393 | -- | -- | 75% 17.95K to 31.34K | |
14-Jun-19 5:34 PM View: | Antares Pharma Inc. (ATRS) | 13-Jun-19 | Grant | 45,205 | $2.92 | $131,999.00 | 100% 0 to 45.2K | 32% |
08-Jun-18 5:01 PM View: | Agile Therapeutics, Inc. (AGRX) | 08-Jun-18 | Option Exercise | 17,949 | -- | -- | 100% 0 to 17.95K | |
16-May-18 7:49 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 14-May-18 | Market Sale (Planned) | 9,348 | $0.52 | $4,881.53 | (4%) 251.4K to 242.05K | 95% |
21-Mar-18 5:16 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 19-Mar-18 | Market Sale (Planned) | 5,950 | $1.70 | $10,115.00 | (2%) 257.35K to 251.4K | 98% |
04-Oct-17 8:32 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 02-Oct-17 | Market Sale (Planned) | 9,960 | $2.50 | $24,917.90 | (4%) 267.31K to 257.35K | 99% |
12-May-17 9:52 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 83,192 | -- | -- | 45% 184.12K to 267.31K | |
17-Mar-17 4:16 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 4,750 | $2.11 | $10,022.50 | 3% 179.37K to 184.12K | (99%) |
23-May-16 4:15 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 20-May-16 | Market Purchase | 10,000 | $3.75 | $37,500.00 | 6% 169.37K to 179.37K | (99%) |
18-May-16 4:31 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 16-May-16 | Market Purchase | 4,500 | $3.79 | $17,037.40 | 3% 164.87K to 169.37K | (99%) |
18-Mar-16 8:57 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 17-Mar-16 | Grant | 47,368 | -- | -- | 40% 117.5K to 164.87K | |
17-Feb-16 9:30 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 12-Feb-16 | Grant | 86,863 | -- | -- | 284% 30.64K to 117.5K | |
09-Feb-16 9:46 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 05-Feb-16 | Acquisition (other) | 30,637 | -- | -- | 100% 0 to 30.64K | |
30-Dec-15 7:14 PM View: | Pozen, Inc. (POZN) | 01-Oct-15 | Grant | 29,137 | -- | -- | 1942% 1.5K to 30.64K | |
30-Jan-15 9:39 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jan-15 | Disposition (other) | 32,634 | $32.73 | $1,067,990.00 | (100%) 32.63K to 0 | (14%) |
26-Nov-14 10:54 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 25-Nov-14 | Option Exercise | 10,562 | $19.12 | $201,931.00 | 30% 35.05K to 45.62K | |
26-Nov-14 10:54 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 25-Nov-14 | Market Option Sale | 10,562 | $34.12 | $360,407.00 | (23%) 45.62K to 35.05K | (1%) |
26-Nov-14 10:54 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 25-Nov-14 | Market Sale | 3,151 | $34.12 | $107,522.00 | (9%) 35.05K to 31.9K | (1%) |
24-Nov-14 4:57 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Nov-14 | Option Exercise | 5,000 | $22.04 | $110,200.00 | 13% 38.7K to 43.7K | |
24-Nov-14 4:57 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Nov-14 | Market Option Sale | 5,000 | $33.47 | $167,346.00 | (11%) 43.7K to 38.7K | (3%) |
24-Nov-14 4:57 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Nov-14 | Market Sale | 3,648 | $33.47 | $122,096.00 | (9%) 38.7K to 35.05K | (3%) |
24-Nov-14 4:57 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 20-Nov-14 | Option Exercise | 66,000 | $16.44 | $1,084,780.00 | 151% 43.7K to 109.7K | |
24-Nov-14 4:57 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 20-Nov-14 | Market Option Sale | 66,000 | $33.15 | $2,188,120.00 | (60%) 109.7K to 43.7K | (4%) |
20-Feb-14 5:39 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Grant | 20,875 | -- | -- | 116% 18.03K to 38.91K | |
20-Feb-14 5:39 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Payment of Exercise | 704 | $28.30 | $19,923.20 | (2%) 38.91K to 38.2K | (22%) |
19-Feb-14 4:29 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 17-Feb-14 | Payment of Exercise | 108 | $26.80 | $2,894.40 | (< 1%) 18.14K to 18.03K | (29%) |
11-Feb-14 9:39 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-14 | Payment of Exercise | 2,043 | $23.68 | $48,378.20 | (10%) 20.18K to 18.14K | (46%) |
11-Feb-13 5:32 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Grant | 17,140 | -- | -- | 747% 2.29K to 19.43K | |
11-Feb-13 5:32 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Payment of Exercise | 426 | $18.30 | $7,795.80 | (2%) 19.43K to 19.01K | (88%) |